Adam Lenkowsky
Evp, Chief Commercialization Officer
Bristol-Myers Squibb Company · BMY
$9.3M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A filed March 25, 2026. Prior years are from that filing's three-year table.
Catalog as of September 15, 2026. Not a live market feed.
- Salary
- $1.1M
- Stock Awards
- $6.1M
- Incentives
- $1.8M
- Other
- $277K
Compensation History
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $1,131,731 | $6,136,800 | $9,340,352 |
Current Position
- Company
- Bristol-Myers Squibb Company
- Title
- Evp, Chief Commercialization Officer
- Ticker
- BMY · NYSE
- Fiscal Year
- 2025
SEC Sources
Fiscal years below are columns from the latest DEF 14A Summary Compensation Table (filed March 25, 2026), not separate historical filings.
| Fiscal Year | Source |
|---|---|
| 2025 | View SEC filing |
Accession 0000014272-26-000006.
Other Bristol Myers Squibb Executives
Christopher S. Boerner
Ph.d.board Chair And Chief Executive Officer
Bristol Myers Squibb · BMY
$21.9M
FY 2025 · DEF 14A
David V. Elkins
EVP and Chief Financial Officer
Bristol Myers Squibb · BMY
$9.2M
FY 2025 · DEF 14A
Cristian Massacesi
, M.D. EVP, Chief Medical Officer, Head of Development
Bristol Myers Squibb · BMY
$10.1M
FY 2025 · DEF 14A
Greg Meyers
EVP, Chief Digital and Technology Officer
Bristol Myers Squibb · BMY
$7.2M
FY 2025 · DEF 14A
Samit Hirawat
, M.D. Former EVP, Chief Medical Officer, Head of Development
Bristol Myers Squibb · BMY
$10.3M
FY 2025 · DEF 14A